Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.155 USD | +2.34% | +3.34% | +11.63% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 462M | |
+9.06% | 105B | |
-0.58% | 104B | |
+5.79% | 22.94B | |
-12.57% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.82% | 16.96B | |
+8.20% | 14.16B | |
+39.22% | 12.63B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Cantor Fitzgerald Adjusts Price Target on Fate Therapeutics to $5 From $8, Maintains Neutral Rating